Consistent Use of Ceramide-Containing Products Combined With … – Dermatology Times

Results from a SCALE 2023 poster presentation1 demonstratedthat the consistent use of ceramide-containing skin care products as monotherapy and adjunctive to prescription treatment improved the signs and symptoms of atopic dermatitis (AD) in pediatric patients. Schachner et al noted that AD commonly starts in infancy and early childhood and is associated with pruritis and genetic predisposition. Previous studies have proven that daily use of moisturizers that contain lipids such as ceramides can reduce the rate of AD flares, and therefore the need for topical steroid treatment.

In the study, Schachner et al gathered a panel of 8 pediatric dermatologists, dermatologists, and pediatricians who treat pediatric AD to report on clinical cases from their practice. The panelists reviewed 15 pediatric AD cases and agreed to select 6 patients covering various presentations of pediatric AD, patient ages, and skin types.

During their evaluations, the panelists discussed why they selected a specific case, previous treatments, type of prevention and education provided, skin care as monotherapy or adjunctive treatment, prescription and non-prescription therapy and maintenance treatment, and clinical pearls. The summary of each patient included:

After discussing the 6 patients and using ceramide-containing skin care products to manage their pediatric AD, the study investigators concluded that Sharing best-practice in AD therapy and maintenance treatment for pediatric eczema patients may support health care providers treating children to improve clinical outcomes. Consistent skincare use with CER-containing cleansers and moisturizers as mono or adjunctive to prescription treatment promoted a healthy skin barrier.

Reference

Follow this link:
Consistent Use of Ceramide-Containing Products Combined With ... - Dermatology Times